DUNXIN FINANCIAL HOLDING-ADR (DXF)

US26605Q2057 - ADR

0.0884  -0.05 (-33.88%)

Fundamental Rating

1

Overall DXF gets a fundamental rating of 1 out of 10. We evaluated DXF against 99 industry peers in the Financial Services industry. DXF may be in some trouble as it scores bad on both profitability and health. DXF is valued expensive and it does not seem to be growing.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DXF has reported negative net income.
In the past year DXF has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: DXF reported negative net income in multiple years.
In multiple years DXF reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -7.46%, DXF is doing worse than 87.38% of the companies in the same industry.
DXF has a Return On Equity of -18.71%. This is amonst the worse of the industry: DXF underperforms 84.47% of its industry peers.
Industry RankSector Rank
ROA -7.46%
ROE -18.71%
ROIC N/A
ROA(3y)-44.29%
ROA(5y)-24.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of DXF (43.63%) is better than 66.02% of its industry peers.
DXF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

2

2. Health

2.1 Basic Checks

DXF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DXF has been increased compared to 1 year ago.
Compared to 5 years ago, DXF has more shares outstanding
The debt/assets ratio for DXF is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.02, we must say that DXF is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of DXF (0.02) is worse than 66.99% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that DXF is somewhat dependend on debt financing.
DXF's Debt to Equity ratio of 0.65 is in line compared to the rest of the industry. DXF outperforms 52.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 0.02
ROIC/WACCN/A
WACC4.82%

2.3 Liquidity

A Current Ratio of 1.87 indicates that DXF should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.87, DXF is doing good in the industry, outperforming 75.73% of the companies in the same industry.
DXF has a Quick Ratio of 1.87. This is a normal value and indicates that DXF is financially healthy and should not expect problems in meeting its short term obligations.
DXF has a better Quick ratio (1.87) than 76.70% of its industry peers.
Industry RankSector Rank
Current Ratio 1.87
Quick Ratio 1.87

More info and screens

0

3. Growth

3.1 Past

DXF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -115.08%.
DXF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -74.96%.
DXF shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -39.80% yearly.
EPS 1Y (TTM)-115.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.2%
Revenue 1Y (TTM)-74.96%
Revenue growth 3Y-52.64%
Revenue growth 5Y-39.8%
Sales Q2Q%-209.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DXF. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DXF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DUNXIN FINANCIAL HOLDING-ADR

NYSEARCA:DXF (9/16/2024, 8:07:25 PM)

0.0884

-0.05 (-33.88%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)09-28 2022-09-28/bmo
Earnings (Next)N/A N/A
Inst Owners0.2%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.17M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)-1.47
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.22
BVpS1.49
TBVpS1.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.46%
ROE -18.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.63%
FCFM N/A
ROA(3y)-44.29%
ROA(5y)-24.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.87
Quick Ratio 1.87
Altman-Z 0.02
F-Score5
WACC4.82%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-115.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-74.96%
Revenue growth 3Y-52.64%
Revenue growth 5Y-39.8%
Sales Q2Q%-209.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y56.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-174.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-174.22%
OCF growth 3YN/A
OCF growth 5YN/A